Pharmacological Inhibition of Small Extracellular Vesicle Secretion by ALK5i SD‐208 via Lysosomal Rerouting of CD63+ Compartments
Journal of Extracellular Vesicles · 2026
DOI: 10.1002/jev2.70362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Rahul Sanwlani und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, University of Surrey, Guildford, UK. Hauptthemen laut MEDLINE: Tetraspanin 30, Receptor, Transforming Growth Factor-beta Type I, Lysosomes, Extracellular Vesicles. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Royal Society, John Jacob Astor Charitable Trust.
Abstract (Originalsprache)
Pharmacological tools to selectively modulate extracellular vesicle (EV) secretion are scarce. Here, we identify the ALK5 (TGF‐β receptor I) inhibitor SD‐208 as a potent suppressor of small EV (sEV) secretion that acts independently of its canonical anti‐fibrotic activity. SD‐208 not only reversed myofibroblast activation but also markedly inhibited sEV secretion. Strikingly, this inhibitory effect persisted in non‐activated cardiac fibroblasts and non‐fibrotic HEK293 cells, demonstrating that SD‐208 regulates EV secretion through mechanisms uncoupled from TGF‐β/Smad signalling. Mechanistic analyses revealed that SD‐208 disrupts vesicle trafficking rather than EV biogenesis. Reduced secretion of CD63 + EVs was accompanied by intracellular accumulation of CD63 + structures and their selective diversion into LAMP1 + lysosomes. Proteomic profiling of SD‐208‐treated and control HEK293 cells and cardiac fibroblasts revealed dysregulation of vesicle trafficking pathways, enrichment of ubiquitin ligase complexes, and enhanced endosome‐to‐lysosome transport. Together, these findings demonstrate that SD‐208 diverts CD63 + multivesicular bodies (MVBs) from a secretory fate toward lysosomal degradation. This work identifies SD‐208 as a small‐molecule tool to interrogate the secretory‐versus‐degradative fate of MVBs and uncovers a new regulatory link between lysosomal pathways and EV trafficking. Beyond its established role as an anti‐fibrotic agent, SD‐208 provides mechanistic and therapeutic opportunities for the control of EV secretion in diseases such as fibrosis, cardiac remodelling, hypertrophic cardiomyopathy, and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences, University of Surrey, Guildford, UK.
- Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia.
- The Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
- Advanced Technology Institute, University of Surrey, Guildford, UK.
- The Hatter Cardiovascular Institute, University College London, London, UK.
- Inherited Cardiovascular Diseases Unit, Barts Heart Centre, London, UK.
ORCID-Profile: Rahul Sanwlani, Sean M Davidson, Suresh Mathivanan, Patrizia Camelliti
Förderung
- British Heart Foundation
- Royal Society
- John Jacob Astor Charitable Trust
Zitieren
APA
Sanwlani, R., Thompson, G. H., Bramich, K., Ang, C. S., Trowbridge, M. L., Duringer, C. E., Stolojan, V., Davidson, S. M., Savvatis, K., McVey, J. H., Mathivanan, S., Clayton, A., & Camelliti, P. (2026). Pharmacological Inhibition of Small Extracellular Vesicle Secretion by ALK5i SD‐208 via Lysosomal Rerouting of CD63+ Compartments. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70362
Vancouver
Sanwlani R, Thompson GH, Bramich K, Ang CS, Trowbridge ML, Duringer CE, et al. Pharmacological Inhibition of Small Extracellular Vesicle Secretion by ALK5i SD‐208 via Lysosomal Rerouting of CD63+ Compartments. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70362
BibTeX
@article{Sanwlani2026,
author = {Sanwlani, Rahul and Thompson, Georgina H and Bramich, Kyle and Ang, Ching-Seng and Trowbridge, Millie L and Duringer, Chris E and Stolojan, Vlad and Davidson, Sean M and Savvatis, Konstantinos and McVey, John H and Mathivanan, Suresh and Clayton, Aled and Camelliti, Patrizia},
title = {Pharmacological Inhibition of Small Extracellular Vesicle Secretion by ALK5i SD‐208 via Lysosomal Rerouting of CD63+ Compartments},
journal = {Journal of Extracellular Vesicles},
year = {2026},
doi = {10.1002/jev2.70362}
}
EUVIMED